Therapy Center of Excellence

The Therapy Center of Excellence is dedicated to all aspects of the development and utilization of Targeted Radioisotope Therapy (TRT) as an alternative to other treatments. The Therapy Center is creating a multi-disciplinary interest group to share ideas, develop education offerings and advance the utilization of radionuclide therapy.


The Therapy Center of Excellence is an organizational component within the SNMMI dedicated to all aspects of the development and utilization of Targeted Radioisotope Therapy as an alternative to other treatments. Specifically, the new center will bring together a centralized group of all constituents within this area creating a multi-disciplinary interest group whereby industry, big pharma, physicians, scientists, government and regulatory agencies as well as other stakeholders can convene to share ideas, develop education offerings and advance the utilization of radionuclide therapy. 

The Therapy Center of Excellence:

(a)  Provides a forum for members with similar interests

(b)  Provides expertise in TRT

(c)  Fosters research and education in TRT

(d)  Provides outreach to other professionals and organizations

(e)  Nurtures new membership in SNMMI


Overview of Proposed Center of Excellence Activities

The center will focus on several initiatives, specific to the SNMMI Strategic Plan Goal C: Increase Appropriate Utilization of Radionuclide Therapy within the first year:

    Objective 1: Assist in the Development of Emerging Agents.

    Objective 2: Advocacy for Regulatory Approval and Reimbursement of Emerging Agents.

    Objective 3: Advanced the Use of Approved Agents.



Hossein Jadvar, MD, PhD, MPH, MBA, FACNM, FSNMMI

I am delighted that I have an opportunity to lead the SNMMI TCOE for the next 2 years along with a capable and knowledgeable Center’s board of directors.  I thank all those who retired this year from their positions within the Center including my predecessor, Dr. Neeta Pandit-Taskar, who contributed much to our Center’s multi-faceted activities over the past 2 years, and also would like to welcome those who have either joined newly or rejoined in a different position within the Center.  We are privileged to have Dr. Thomas Hope (UCSF) as the Vice-President and Dr. Carlos Uribe (British Columbia Cancer Research) as the new Secretary-Treasurer.  I also take this opportunity to welcome our new intern, Dr. Ashwin Parihar (Washington University) who will be mentored by Dr. Patrick Colletti (USC) and congratulate Dr. Amir Iravani (University of Washington, Seattle), board member, who received the highest prized inaugural SNMMI Mars Shot funding for his research proposal entitled “Phase II trial of biomarker modulated PSMA theranostics”.  

 We are in unprecedented times with rapid growth of and scientific advancements in theranostics and radiopharmaceutical therapy.  There is much to be excited about with an optimistic view of the near and the far future.  However, there are many challenges ahead too that needs to be tackled with.  These include, but are not limited to, adequate education, supply issues (both physicians and radiopharmaceuticals), potential turf scuffles, and need for generation of high-quality evidence in supporting radiopharmaceutical therapy as a legitimate therapeutic option that improves patient outcome, “adding time to life and life to time”.  We, in the Therapy Center of Excellence, are fortunate to have been trusted to help with supporting and contributing in multiple ways to the field of theranostics and radiopharmaceutical therapy.  I call on the Center’s board members to contribute to our goals despite their busy lives and ask the SNMMI members to join our team with their Center membership so that we can all work together toward our overarching objective of serving our patients.  We also welcome international partnerships in this arena and will reach out to strengthen our collaborations. 

The Saul Hertz, MD Award
SNMMI has established The Dr. Saul Hertz Lifetime Achievement Award in honor of the professional achievements of Dr. Hertz as the pioneer of Radioiodine Therapy. The award recognizes individuals who have made outstanding contributions to radionuclide therapy. To learn more about the Saul Hertz, MD award, click here.

2024 Saul Hertz, MD Award Winner

2023 Saul Hertz, MD Award Winner

2022 Saul Hertz, MD Award Winner

2021 Saul Hertz, MD Award Winner

2020 Saul Hertz, MD Award Winner

2019 Saul Hertz, MD Award Winner

2018 Saul Hertz, MD Award Winner

2017 Saul Hertz, MD Award Winner

2016 Saul Hertz, MD Award Winner


Therapy Center of Excellence Young Investigator Awards

The Therapy Center of Excellence is pleased to offer the Young Investigator Awards (YIAs) which are supported by grants from the Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF). 

2023 Young Investigator Awards

2022 Young Investigator Awards

2021 Young Investigator Awards

2020 Young Investigator Awards

2019 Young Investigator Awards

2018 Young Investigator Awards

2017 Young Investigator Awards

2016 Young Investigator Awards


SNMMI 2024 Annual Meeting
June 8-11, 2024 | Toronto, Canada

The premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging, the SNMMI Annual Meeting provides physicians, technologists, pharmacists, laboratory professionals, and scientists with an in-depth view of the latest research and development in the field as well as providing insights into practical applications for the clinic.

Meeting website

Membership Dues

Membership dues is $15 annually.

Member Benefits

Member benefits include:

 - Eligibility to vote in the Therapy COE Board of Directors elections

 - Newsletter

 - Sponsored educational symposia related to members’ interests

 - Therapy CoE E-Community

 - A $20.00 discount for Therapy CoE sponsored categorical session


Join The Therapy Center of Excellence 

- or -

Forward your request in writing with your check for annual center dues ($15) to SNMMI Membership Services, 1850 Samuel Morse Drive, Reston, VA 20190-5316. If you have any further questions about the Therapy Center of Excellence membership, please contact


Radiopharmaceutical Therapy Centers of Excellence

SNMMI designated Centers of Excellence in Radiopharmaceutical Therapy meet strict regulatory, training, qualification, experience, and performance criteria to help assure patients, their families, referring physicians, and payors that rigorous procedures are in place and followed, leading to appropriate patient selection and outcomes from radiopharmaceutical therapy.

Learn more about designating your therapy site as a Center of Excellence.

   Therapy Center of Excellence Resources